Shuomoo technology, a chronic disease diagnosis and treatment company, has completed tens of millions of strategic financing

0
295

Recently, shuomoo technology, a chronic disease diagnosis and treatment company, has completed tens of millions of strategic financing. This round of financing is invested by aptar, a packaging solution provider in the medical and consumer industries. LanChi venture capital is a round a investor of shuomoo technology.
This round of financing will be used for the promotion and commercialization of the core product – disease diagnosis and treatment management system, to establish a deeper cooperation and business model with the hospital, and to strengthen the talent reserve and echelon construction.
As a strategic investor, aptar will cooperate with shuomoo technology in the field of digital disease management platform and algorithm, accelerate the development, manufacturing, commercialization and supply of respiratory drugs that have been listed and are under development, and realize the digitalization of drug delivery, diagnosis and patient support.